Michail Kalaitzakis is a Principal Global Program Manager in Portfolio and Product Development Strategy at Roche, where they have held various roles since 2021. Prior to this, they consulted as a Medical Science Consultant at Round Table Group from 2009 to 2013. Michail's extensive academic background includes a PhD in Neuropathology/Neuroscience from Imperial College London, as well as a MSc in Integrative Neuroscience and an MA in Health Management & Economics. Additionally, they served as an Honorary Research Fellow and Honorary Lecturer at Imperial College London, and worked as a Medical Scientific Liaison at Novartis.
This person is not in any teams
This person is not in any offices